Pharmaceutical

Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s disease

Johnson & Johnson (J&J) has submitted an sBLA seeking approval from the US FDA for Tremfya (guselkumab) to treat Crohn’s disease.

Jun 22, 2024 - 04:00
Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s disease
Johnson & Johnson (J&J) has submitted an sBLA seeking approval from the US FDA for Tremfya (guselkumab) to treat Crohn’s disease.
Read the original article

Tags:

Previous Article

Emergent to sell US sterile manufacturing facility to Bora

Next Article

Sanofi and Biovac partner to produce polio vaccines in Africa

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Sam Waksal and Jeremy Levin plot ‘the turnaround story of the century’

STAT+: Sam Waksal and Jeremy Levin plot ‘the turnaround...

May 1, 2023

Watch: In a children’s hospital gardens, families find sanctuary

Watch: In a children’s hospital gardens, families find ...

Jul 24, 2023

The White House has a pharmacy — and it was a mess, a new investigation found

The White House has a pharmacy — and it was a mess, a n...

Jan 24, 2024